GH Research Plc (GHRS)
27.36
+0.38
(+1.41%)
USD |
NASDAQ |
Sep 01, 16:00
27.30
-0.06
(-0.22%)
Pre-Market: 08:36
GH Research Net Income (TTM) : -62.27M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -62.27M |
| March 31, 2026 | -56.41M |
| December 31, 2025 | -48.26M |
| September 30, 2025 | -42.92M |
| June 30, 2025 | -41.02M |
| March 31, 2025 | -42.11M |
| December 31, 2024 | -38.96M |
| September 30, 2024 | -41.43M |
| June 30, 2024 | -34.97M |
| March 31, 2024 | -32.32M |
| Date | Value |
|---|---|
| December 31, 2023 | -35.59M |
| September 30, 2023 | -40.90M |
| June 30, 2023 | -35.69M |
| March 31, 2023 | -27.63M |
| December 31, 2022 | -22.46M |
| September 30, 2022 | -9.961M |
| June 30, 2022 | -11.36M |
| March 31, 2022 | -13.82M |
| December 31, 2021 | -9.202M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Atai Beckley, Inc. | -668.29M |
| Avadel Pharmaceuticals Plc | -0.278M |
| Jazz Pharmaceuticals Plc | 940.76M |
| Eli Lilly & Co. | 26.71B |
| Perrigo Co. Plc | -1.703B |